Tokio Marine Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.82M | Buy |
20,091
+638
| +3% | +$53.4K | 0.06% | 266 |
|
|
2026
Q1 | $1.56M | Hold |
19,453
| – | – | 0.06% | 261 |
|
|
2025
Q4 | $1.66M | Buy |
19,453
+348
| +2% | +$28.6K | 0.06% | 242 |
|
|
2025
Q3 | $1.49M | Buy |
19,105
+289
| +2% | +$22.6K | 0.05% | 267 |
|
|
2025
Q2 | $1.47M | Hold |
18,816
| – | – | 0.06% | 250 |
|
|
2025
Q1 | $1.36M | Hold |
18,816
| – | – | 0.05% | 268 |
|
|
2024
Q4 | $1.39M | Buy |
18,816
+676
| +4% | +$47.3K | 0.05% | 262 |
|
|
2024
Q3 | $1.2M | Buy |
18,140
+1,480
| +9% | +$108K | 0.05% | 259 |
|
|
2024
Q2 | $1.54M | Buy |
16,660
+942
| +6% | +$83.4K | 0.07% | 189 |
|
|
2024
Q1 | $1.5M | Buy |
15,718
+1,669
| +12% | +$140K | 0.08% | 197 |
|
|
2023
Q4 | $1.07M | Sell |
14,049
-616
| -4% | -$42.9K | 0.06% | 228 |
|
|
2023
Q3 | $1.02M | Buy |
14,665
+2,012
| +16% | +$162K | 0.06% | 203 |
|
|
2023
Q2 | $1.19M | Sell |
12,653
-24
| -0.2% | -$2.09K | 0.08% | 178 |
|
|
2023
Q1 | $1.05M | Buy |
12,677
+1,934
| +18% | +$152K | 0.07% | 192 |
|
|
2022
Q4 | $802K | Buy |
10,743
+936
| +10% | +$72.1K | 0.06% | 211 |
|
|
2022
Q3 | $810K | Buy |
9,807
+1,184
| +14% | +$114K | 0.07% | 185 |
|
|
2022
Q2 | $820K | Buy |
8,623
+1,438
| +20% | +$149K | 0.07% | 182 |
|
|
2022
Q1 | $846K | Buy |
7,185
+1,044
| +17% | +$117K | 0.07% | 175 |
|
|
2021
Q4 | $796K | Buy |
6,141
+509
| +9% | +$59.4K | 0.06% | 180 |
|
|
2021
Q3 | $638K | Buy |
5,632
+544
| +11% | +$62.1K | 0.06% | 199 |
|
|
2021
Q2 | $527K | Buy |
5,088
+689
| +16% | +$64.9K | 0.05% | 205 |
|
|
2021
Q1 | $368K | Buy |
4,399
+756
| +21% | +$63.9K | 0.04% | 234 |
|
|
2020
Q4 | $332K | Hold |
3,643
| – | – | 0.04% | 240 |
|
|
2020
Q3 | $291K | Buy |
3,643
+305
| +9% | +$23.8K | 0.04% | 224 |
|
|
2020
Q2 | $231K | Buy |
+3,338
| New | +$237K | 0.03% | 228 |
|
|
2017
Q4 | – | Sell |
-5,892
| Closed | -$215K | – | 313 |
|
|
2017
Q3 | $215K | Sell |
5,892
-1,896
| -24% | -$72.3K | 0.03% | 322 |
|
|
2017
Q2 | $307K | Sell |
7,788
-2,478
| -24% | -$90.4K | 0.04% | 293 |
|
|
2017
Q1 | $322K | Sell |
10,266
-3,321
| -24% | -$104K | 0.04% | 324 |
|
|
2016
Q4 | $424K | Sell |
13,587
-4,656
| -26% | -$151K | 0.05% | 247 |
|
|
2016
Q3 | $733K | Sell |
18,243
-2,601
| -12% | -$98K | 0.08% | 200 |
|
|
2016
Q2 | $693K | Sell |
20,844
-1,872
| -8% | -$64K | 0.07% | 229 |
|
|
2016
Q1 | $668K | Buy |
22,716
+2,796
| +14% | +$77.1K | 0.07% | 246 |
|
|
2015
Q4 | $524K | Sell |
19,920
-4,962
| -20% | -$129K | 0.06% | 279 |
|
|
2015
Q3 | $590K | Sell |
24,882
-942
| -4% | -$22.7K | 0.06% | 266 |
|
|
2015
Q2 | $613K | Sell |
25,824
-3,942
| -13% | -$89K | 0.06% | 279 |
|
|
2015
Q1 | $707K | Sell |
29,766
-4,056
| -12% | -$91K | 0.07% | 284 |
|
|
2014
Q4 | $718K | Sell |
33,822
-3,474
| -9% | -$69.8K | 0.06% | 307 |
|
|
2014
Q3 | $635K | Hold |
37,296
| – | – | 0.05% | 420 |
|
|
2014
Q2 | $534K | Hold |
37,296
| – | – | 0.04% | 473 |
|
|
2014
Q1 | $461K | Hold |
37,296
| – | – | 0.03% | 489 |
|
|
2013
Q4 | $409K | Hold |
37,296
| – | – | 0.03% | 501 |
|
|
2013
Q3 | $433K | Hold |
37,296
| – | – | 0.03% | 502 |
|
|
2013
Q2 | $418K | Buy |
+37,296
| New | +$441K | 0.03% | 508 |
|
Other funds holding EW
Tokio Marine Asset Management's EW Position: Q2 2026 in Review
Tokio Marine Asset Management increased its Edwards Lifesciences (EW) stake by 3.3% in Q2 2026, buying an estimated $53.4K and bringing the position to 20,091 shares worth $1.82M. The position accounts for 0.06% of the portfolio, ranked #266.
Tokio Marine Asset Management first reported a position in EW in Q2 2013 and has held it in 43 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Tokio Marine Asset Management held 20,091 shares of Edwards Lifesciences worth $1.82M as of Q2 2026.
- Tokio Marine Asset Management bought 638 Edwards Lifesciences shares in Q2 2026, an estimated $53.4K.
- Edwards Lifesciences made up 0.06% of Tokio Marine Asset Management's portfolio in Q2 2026, its #266 holding.
- Tokio Marine Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 43 quarters since.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.